Get trade alerts

Genmab A/S ($GMAB) Insider Trading & Smart Money Activity

Genmab A/S · Biotechnology · Latest filing Oct 7, 2026

Genmab A/S ($GMAB) has 1 congress trade and 5 analyst ratings on file.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
0
Net insider $ (12 mo)
$0
Congress trades (12 mo)
1
13F moves on file
0
Analyst ratings on file
5

GMAB insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 1 / 0 0 / 0
Q2 2026 0 0 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All GMAB insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Analyst Truist Securities Reiterates to Buy PT $45 +0.7% —
Analyst HC Wainwright Reiterates to Buy PT $50 +0.7% —
Analyst Guggenheim Reiterates to Buy PT $58 +0.7% —
Analyst Guggenheim Reiterates to Buy PT $54 -2.9% —
Analyst HC Wainwright Reiterates to buy PT $38 +5.9%+12.5% Read
Congress Alan Armstrong Purchase $1,001 - $15,000 +7.4%+1.1%+36.9% —

1W / 1M / 6M = how GMAB moved from the trade or filing date.

Members of Congress trading GMAB

Analyst ratings on GMAB

DateFirmActionRatingPrice target1W1M6MStory
Truist Securities Reiterates Buy $40 → $45 +0.7% —
HC Wainwright Reiterates Buy $40 → $50 +0.7% —
Guggenheim Reiterates Buy $54 → $58 +0.7% —
Guggenheim Reiterates Buy $45 → $54 -2.9% —
HC Wainwright Reiterates buy $38 +5.9%+12.5% Read

Frequently asked questions

Which members of Congress traded GMAB?

1 disclosed trade by Alan Armstrong. The latest was on Mar 30, 2026.

Other biotechnology stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text